<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evolution of histologic grading for neuroendocrine neoplasms based on mitotic count and Ki-67 labeling index, by classification and year</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evolution of histologic grading for neuroendocrine neoplasms based on mitotic count and Ki-67 labeling index, by classification and year</h1>
<div class="graphic"><div class="figure"><div class="ttl">Evolution of histologic grading for neuroendocrine neoplasms based on mitotic count and Ki-67 labeling index, by classification and year</div><div class="cntnt"><table cellspacing="0"><colgroup width="8%"></colgroup><colgroup width="4%"></colgroup><colgroup span="7" width="8%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2"> </td> <td class="subtitle1">Moran<sup>[1]</sup> (2000)</td> <td class="subtitle1"> <p>WHO<sup>[2]</sup> (2004)</p> WHO<sup>[3]</sup> (2015)</td> <td class="subtitle1">WHO<sup>[4]</sup> (2000)</td> <td class="subtitle1"> <p>Hochwald<sup>[5]</sup> (2002)</p> AFIP<sup>[6]</sup> (2007)</td> <td class="subtitle1">WHO<sup>[7]</sup> (2004)</td> <td class="subtitle1"> <p>ENETS<sup>[8,9]</sup> (2006)</p> <p>AJCC<sup>[10]</sup> (2009)</p> WHO<sup>[11]</sup> (2010)</td> <td class="subtitle1">WHO<sup>[12]</sup> (2019)</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Organ system</strong></td> <td>Thymus</td> <td>Lung, thymus</td> <td>GI</td> <td>Pancreas</td> <td>Pancreas</td> <td>GI, pancreas</td> <td>GI, pancreas, hepatobiliary</td> </tr> <tr> <td class="divider_bottom" rowspan="3"><strong>Mitotic index</strong></td> <td>G1</td> <td>&lt;3/10 HPF</td> <td>&lt;2/2 mm<sup>2</sup></td> <td>NA</td> <td>&lt;2/50 HPF</td> <td>&lt;2/2 mm<sup>2</sup></td> <td>&lt;2/2 mm<sup>2</sup></td> <td>&lt;2/2 mm<sup>2</sup></td> </tr> <tr> <td>G2</td> <td>4 to 9/10 HPF</td> <td>2 to 10/2 mm<sup>2</sup></td> <td>NA </td> <td>2 to 10/50 HPF</td> <td>2 to 10/2 mm<sup>2</sup></td> <td>2 to 20/2 mm<sup>2</sup></td> <td>2 to 20/2 mm<sup>2</sup></td> </tr> <tr class="divider_bottom"> <td>G3</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>&gt;20/2 mm<sup>2</sup></td> <td>&gt;20/2 mm<sup>2</sup></td> </tr> <tr> <td class="divider_bottom" rowspan="3"><strong>Ki-67</strong></td> <td>G1</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>&lt;2%</td> <td>≤2% (&lt;3%)</td> <td>&lt;3%</td> </tr> <tr> <td>G2</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>&gt;2%</td> <td>3 to 20%</td> <td>3 to 20%</td> </tr> <tr class="divider_bottom"> <td>G3</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>&gt;20%</td> <td>&gt;20%</td> </tr> <tr> <td colspan="2"><strong>Other parameters</strong></td> <td>Necrosis</td> <td>Necrosis</td> <td>Size, invasion, metastasis</td> <td>Necrosis</td> <td>Size, invasion, metastasis</td> <td>None</td> <td>Assessment of morphology and marker expression helps to differentiate from poorly differentiated neuroendocrine carcinoma</td> </tr> </tbody></table></div><div class="graphic_lgnd">G1: Low grade, benign behavior, or typical carcinoid (lung and thymus).<br/>G2: Intermediate grade, uncertain behavior, or atypical carcinoid (lung and thymus).<br/>G3: High grade. In earlier classifications, G3 equated to poorly differentiated neuroendocrine carcinoma. The 2017 WHO classification of pancreatic neuroendocrine neoplasms first recognized G3 well-differentiated neuroendocrine tumors in addition to poorly differentiated neuroendocrine carcinoma. For well-differentiated pancreatic neuroendocrine tumors, G3 is diagnosed mostly based on Ki-67 labeling index, in correlation with well-differentiated morphology and aided by appropriate marker expression in difficult cases. The mitotic count in this new category generally is in the G2 range.</div><div class="graphic_footnotes">WHO: World Health Organization; AFIP: Armed Forces Institute of Pathology; ENETS: European Neuroendocrine Tumour Society; AJCC: American Joint Committee on Cancer; GI: gastrointestinal; HPF: high-power field; NA: not applicable.</div><div class="graphic_reference">References: 

<ol>
<li>Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000; 114:100.</li>
<li>Travis WD. The concept of pulmonary neuroendocrine tumours. In: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (Eds), IARC Press, Lyon 2004. p.19.</li>
<li>WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, 4th ed, Travis WD, Brambilla E, Burke AP, et al (Eds), IARC Press, Lyon 2015.</li>
<li>WHO Classification of Tumours of the Digestive System, Hamilton SR, Aaltonen LA (Eds), IARC Press, Lyon 2000.</li>
<li>Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20:2633.</li>
<li>Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: AFIP Atlas of Tumor Pathology, 6th ed, ARP/AFIP, Washington, DC 2007. p.422.</li>
<li>Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004; 1014:13.</li>
<li>Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449:395.</li>
<li>Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007; 451:757.</li>
<li>Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual, 7th ed, Springer, New York 2010.</li>
<li>WHO Classification of Tumours of the Digestive System, Bosman F, Carneiro F, Hruban R, et al (Eds), IARC Press, Lyon 2010.</li>
<li>WHO Classification of Digestive System Tumours, 5th ed, WHO Classification of Tumours Editorial Board (Ed), IARC Press, Lyon 2019.</li></ol></div><div id="graphicVersion">Graphic 54667 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
